Evidence map›Paper›PMID 40142599›Full record

ArticleJournal of clinical medicine2025

Isolated Liver Recurrence After Cytoreduction in High-Grade Serous Ovarian Carcinoma: Experience of a Tertiary Center in Turkey.

Hande Esra Koca Yıldırım, İzzet Özgürlük, Burak Ersak, Dilek Yüksel, Eyüp Gökhan Turmuş, Baran Yeşil, Çiğdem Kılıç, Sevgi Koç, Nurettin Boran, Sadun Sucu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hande Esra Koca YıldırımDepartment of Gynecologic Oncology, Ümraniye Training and Research Hospital, 34764 İstanbul, Turkey.ORCID 0000-0002-3715-9424
İzzet ÖzgürlükDepartment of Obstetrics and Gynecology, Ankara Bilkent City Hospital, 06800 Ankara, Turkey.ORCID 0000-0002-9553-9265
Burak ErsakDepartment of Gynecologic Oncology, Ankara Etlik City Hospital, 06710 Ankara, Turkey.
Dilek YükselDepartment of Gynecologic Oncology, Ankara Etlik City Hospital, 06710 Ankara, Turkey.
Eyüp Gökhan TurmuşDepartment of Gynecologic Oncology, Ankara Etlik City Hospital, 06710 Ankara, Turkey.
Baran YeşilDepartment of Gynecologic Oncology, Ankara Etlik City Hospital, 06710 Ankara, Turkey.ORCID 0009-0000-4790-0880
Çiğdem KılıçDepartment of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, 06100 Ankara, Turkey.ORCID 0000-0002-4433-8068
Sevgi KoçDepartment of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, 06100 Ankara, Turkey.
Nurettin BoranDepartment of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, 06100 Ankara, Turkey.
Sadun SucuDepartment of Perinatology, Ankara Etlik City Hospital, 06710 Ankara, Turkey.
Caner ÇakırDepartment of Gynecologic Oncology, Ankara Etlik City Hospital, 06710 Ankara, Turkey.ORCID 0000-0003-2559-9104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hepatic metastaseshigh-grade serous ovarian cancer

Identifiers

PMID40142599
PMCPMC11942783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.